211 related articles for article (PubMed ID: 37259801)
1. Categorizing Risks within Barrett's Esophagus To Guide Surveillance and Interception; Suggesting a New Framework.
Honing J; Fitzgerald RC
Cancer Prev Res (Phila); 2023 Jun; 16(6):313-320. PubMed ID: 37259801
[TBL] [Abstract][Full Text] [Related]
2. Surveillance in Barrett's esophagus: an audit of practice.
Ajumobi A; Bahjri K; Jackson C; Griffin R
Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
[TBL] [Abstract][Full Text] [Related]
3. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.
Kamboj AK; Katzka DA; Iyer PG
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):27-41. PubMed ID: 33213798
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
Whitson MJ; Falk GW
Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide.
Ghaus S; Neumann H; Muhammad H; Tontini GE; Ishaq S
Dig Dis Sci; 2016 Aug; 61(8):2185-2193. PubMed ID: 27038446
[TBL] [Abstract][Full Text] [Related]
7. Cancer Risk in Barrett's Esophagus: A Clinical Review.
Beydoun AS; Stabenau KA; Altman KW; Johnston N
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046992
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic therapy of esophageal premalignancy and early malignancy.
Nealis TB; Washington K; Keswani RN
J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219
[TBL] [Abstract][Full Text] [Related]
9. [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?].
Sostres C; Lacarta P; Lanas A
Gastroenterol Hepatol; 2013 Oct; 36(8):520-6. PubMed ID: 23453559
[TBL] [Abstract][Full Text] [Related]
10. Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma.
Cotton CC; Eluri S; Shaheen NJ
Gastroenterol Clin North Am; 2022 Sep; 51(3):485-500. PubMed ID: 36153106
[TBL] [Abstract][Full Text] [Related]
11. Advanced Endoluminal Technologies for Barrett's Esophagus: Focus on Optical Coherence Tomography and Confocal Laser Endomicroscopy.
Zihni AM; DeMeester SR
Thorac Surg Clin; 2018 Nov; 28(4):465-472. PubMed ID: 30268292
[TBL] [Abstract][Full Text] [Related]
12. Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression.
Klaver E; Bureo Gonzalez A; Mostafavi N; Mallant-Hent R; Duits LC; Baak B; Böhmer CJM; van Oijen AHAM; Naber T; Scholten P; Meijer SL; Bergman JJGHM; Pouw RE;
United European Gastroenterol J; 2021 Oct; 9(8):929-937. PubMed ID: 34228885
[TBL] [Abstract][Full Text] [Related]
13. Screening and surveillance for Barrett's esophagus: current issues and future directions.
Choi SE; Hur C
Curr Opin Gastroenterol; 2012 Jul; 28(4):377-81. PubMed ID: 22508325
[TBL] [Abstract][Full Text] [Related]
14. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?
Kunzmann AT; Coleman HG; Johnston BT; Turkington RC; McManus D; Anderson LA; Thrift AP
Dig Dis Sci; 2021 Jun; 66(6):1965-1973. PubMed ID: 32734400
[TBL] [Abstract][Full Text] [Related]
15. Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management.
Dent J
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():11-30. PubMed ID: 21199510
[TBL] [Abstract][Full Text] [Related]
16. Best Practices in Surveillance for Barrett's Esophagus.
Triggs JR; Falk GW
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):59-75. PubMed ID: 33213800
[TBL] [Abstract][Full Text] [Related]
17. Screening and surveillance for complications related to gastroesophageal reflux disease.
Spechler SJ
Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
[TBL] [Abstract][Full Text] [Related]
18. Who Deserves Endoscopic Screening for Esophageal Neoplasia?
Blevins CH; Iyer PG
Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):365-378. PubMed ID: 28577762
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
20. Barrett's esophagus surveillance: When, how often, does it work?
Katona BW; Falk GW
Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):9-24. PubMed ID: 21112494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]